ACM
INGN icon

Anfield Capital Management’s Inogen INGN Stock Holding History

Anfield Capital Management’s Portfolio INGN Stock Details INGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-58
Closed -$468 – 466
2024
Q1 		$468 Buy
+58
New +$410 ﹤0.01% 310

Other funds holding INGN

DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Fred Alger Management
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Anfield Capital Management's INGN Position: Q2 2024 in Review

Anfield Capital Management sold out of Inogen (INGN) in Q2 2024, closing a stake of 58 shares — an estimated $468 sold.

Anfield Capital Management first reported a position in INGN in Q1 2024 and held it in 1 quarter. The position peaked at $468 in Q1 2024. 130 funds tracked by Wall St. Rank hold INGN as of Q2 2024.

  • Anfield Capital Management reported no remaining Inogen position as of Q2 2024 after selling out during the quarter.
  • Anfield Capital Management sold 58 Inogen shares in Q2 2024, an estimated $468.
  • Anfield Capital Management first reported a position in Inogen in Q1 2024 and held it in 1 quarter.
  • Anfield Capital Management's Inogen position peaked at $468 in Q1 2024.
  • 130 funds tracked by Wall St. Rank held Inogen as of Q2 2024.

Based on Anfield Capital Management's 13F filing for Q2 2024, filed 31 Jul 2024.